Dean Lee

To Lead Cell Therapy Programs at Nationwide Childrens Hospital and The Ohio State University Comprehensive Cancer Center · Nationwide Children's Hospital

Credentials: · · · · ·

History

Pediatric Hematology/Oncology
Baylor College of Medicine
2003–2006
Pediatrics
Loma Linda University Children's Hospital
2000–2003
Loma Linda University School of Medicine
1996–2000
Fresno Pacific College

Research

Membrane-bound IL-21 promotes sustained ex vivo proliferation of human natural killer cells
PLoS ONE · 2012 · Last of 13 authors · Corresponding · 555 citations
A foundation for universal T-cell based immunotherapy: T cells engineered to express a CD19-specific chimeric-antigen-receptor and eliminate expression of endogenous TCR
Blood · 2012 · 429 citations
Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells
Journal of Clinical Investigation · 2016 · 410 citations

LC
Laurence Cooper
38 papers
Richard Champlin
35 papers
Mitchell Cairo
17 papers
Elizabeth Shpall
16 papers
Partow Kebriaei
14 papers
GB
Gregory Behbehani
13 papers
Timothy Cripe
13 papers
Margaret Lamb
10 papers · 4 as a fellow
Stefan Ciurea
10 papers
Kevin Cassady
7 papers
Marcos de Lima
7 papers
Jeremy Rosenblum
6 papers

Grants

Novel Immunomodulation and Facilitation of “Suppression Proof” CAR NK Cell Against Ewing Sarcoma
National Cancer Institute · U54
Project lead · $1.9M · Research Inst Nationwide Children's Hosp
2025
MHC Restricted Immunotherapeutic Targets in AML
National Cancer Institute · R21
Contact PI · $255K · University of Tx Md Anderson Can Ctr
2005–2009

Clinical trials

BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus
Study chair · Recruiting · Phase 1
Luminary Therapeutics
2025–2026